Czarnowska E, Karwatowska-Prokopczuk E, Kurzydlowski K
Department of Pathology, Children's Memorial Health Institute, Warsaw, Poland.
Basic Res Cardiol. 1998 Aug;93(4):269-75. doi: 10.1007/s003950050095.
Among factors underlying reperfusion injury are oxygen free radicals and Ca2+ influx via gated calcium channel or via Na+/H(+)-Na+/Ca2+ exchange which lead to calcium overload. The aim of the study was to ultrastructurally visualize the distribution of Ca2+ and to compare binding of calcium by the sarcolemma and calcium accumulation in mitochondria under therapy with an OH scavenger, dimethylthiourea (DMTU), Na+/H+ exchange inhibitor, amiloride, and calcium channel blocker, diltiazem, given alone or in combination to ischemic/reperfused hearts. Isolated working hearts subjected to 40 min ischemia and 30 min reperfusion were perfused with drugs added to the perfusate 15 min before ischemia and administered for the rest of the perfusion period. The cytochemical phosphate pyroantimonate method for localization of Ca2+ was used, and calcium distribution was analyzed with a computer image analyzer. All drugs given alone improved sarcolemmal ability to bind calcium. The best results were obtained with amiloride. All of the combined therapies gave even better results, but calcium accumulation in mitochondria diminished only with diltiazem therapy given alone or in combination with DMTU. Since the presence of Ca2+ deposits on the sarcolemma is believed to represent its normal function, and calcium sequestration by mitochondria reflects an increase in cytosolic calcium load, the lack of correlation between sarcolemmal and mitochondrial Ca2+ distribution might suggest impaired mechanisms of lowering cytoplasmic calcium or the existence of some mechanism other than Na+/Ca2+ exchange, mediated by activated Na+/H+ exchange.
再灌注损伤的潜在因素包括氧自由基以及通过门控钙通道或通过钠/氢(+)-钠/钙交换的钙离子内流,这会导致钙超载。本研究的目的是通过超微结构观察钙离子的分布,并比较在使用羟基清除剂二甲基硫脲(DMTU)、钠/氢交换抑制剂阿米洛利和钙通道阻滞剂地尔硫卓单独或联合治疗缺血/再灌注心脏时,肌膜对钙的结合以及线粒体中钙的积累情况。对离体工作心脏进行40分钟缺血和30分钟再灌注处理,在缺血前15分钟将药物添加到灌注液中进行灌注,并在剩余灌注期持续给药。采用细胞化学焦锑酸磷酸法定位钙离子,并用计算机图像分析仪分析钙分布。所有单独使用的药物均改善了肌膜结合钙的能力。阿米洛利取得了最佳效果。所有联合治疗效果更佳,但仅地尔硫卓单独或与DMTU联合治疗时线粒体中的钙积累减少。由于肌膜上钙沉积物的存在被认为代表其正常功能,而线粒体对钙的螯合反映了细胞质钙负荷的增加,肌膜和线粒体钙分布之间缺乏相关性可能表明降低细胞质钙的机制受损,或者存在除由激活的钠/氢交换介导的钠/钙交换之外的某些机制。